POET Technologies: A Photonics Pioneer Navigates a Legal Storm While Racing Toward Volume Production

POET Technologies faces a 68% stock decline after Marvell canceled orders, triggering class-action lawsuits, as the company races to prove its optical engine production can deliver revenue by 2026.

The optics of POET Technologies' current position are as contradictory as the signals traveling through its optical engines. The company's shares closed at €6.09 on Friday, shedding 8.83% in a single session, and have now cratered nearly 68% from the 52-week high of €18.84 reached in mid-May. But beneath the surface of this sell-off lies a company attempting to execute a high-stakes pivot from design-stage promise to manufacturing reality, all while fending off legal challenges and rebuilding credibility.

The Marvell Fallout and Its Legal Aftermath

The catalyst for the current turmoil traces back to late April, when Marvell Semiconductor canceled all outstanding orders after acquiring Celestial AI. The move blindsided POET and triggered a cascade of consequences. Multiple law firms filed securities class actions, with the Rosen Law Firm taking the lead. The lawsuits name CEO Suresh Venkatesan and CFO Thomas Mika personally, alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

The core accusation centers on an April 21 interview in which Mika allegedly discussed POET's business relationship with Celestial AI and Marvell, despite being bound by a confidentiality agreement. Celestial AI responded by terminating all orders, sending POET's shares down more than 45% in a single trading day on April 27. The class action covers investors who purchased POET shares between April 1 and 8:57 a.m. Eastern Time on April 27. The case, filed in the U.S. District Court for the District of New Jersey, remains in its early stages with class certification still pending.

A Production Timeline That Demands Results

Management is attempting to counter the crisis with concrete milestones. The company has reaffirmed its target to begin high-volume production of its optical engines in the second half of 2026, a timeline reiterated by both the board and management during the June annual general meeting. The critical question is whether POET can transition from the "design-in" phase to actual revenue-generating mass production.

The Marvell cancellation has raised the bar considerably. The market now demands tangible proof that POET's optical interposer platform can fulfill the recently announced $50 million Lumilens order. Other ongoing customer projects must also translate into meaningful revenue beyond development fees. The current market capitalization of approximately €418 million requires operational justification, not just speculative potential.

Mixed Signals from the Operating Front

There are glimmers of operational progress. POET is working with partner Lessengers on a 1.6T-2×DR4 transceiver module, with initial samples expected in the second quarter of 2026. A new technology customer has placed a $5 million order, suggesting that demand for the Infinity Optical Engines hasn't collapsed despite the Marvell setback. Retail investors on platforms like Moomoo have pointed to aggressive hiring at manufacturing partners Globetronics and Nationgates in Penang as a potential signal that mass production is approaching.

Yet the governance picture remains troubled. CFO Thomas Mika has informed the board of his intention to leave the company during 2026, creating leadership uncertainty at a critical juncture. The long-serving finance chief's departure adds to the credibility damage inflicted by the lawsuits, which also allege that POET misrepresented its U.S. tax status as a Passive Foreign Investment Company.

Technical and Market Pressures

The stock's technical position offers little comfort. The 14-day relative strength index sits at 36.2, indicating oversold conditions that could attract bargain hunters. But the shares trade roughly 11% below their 200-day moving average of €6.85, a level that has flipped from support to resistance. With 30-day annualized volatility exceeding 93%, the stock remains highly sensitive to any new development.

The broader semiconductor sector is also correcting, adding to the downward pressure. A deadline for the class action passed on June 29, further weighing on sentiment. Citadel disclosed a passive stake of 5.1% to 5.9% as of July 8, suggesting some institutional interest, but a Seeking Alpha analysis has reiterated a "Strong Sell" rating, noting that the stock has lost roughly 60% from its highs despite the company raising about $830 million in capital and confirming its production ramp plans.

The Quarter Ahead

Until the stock reclaims its 50-day moving average of €9.60, the short-term trend remains under pressure. The next major catalyst is the second-quarter 2026 earnings report, expected in August, though POET has not confirmed an exact date. That report will reveal how deeply the Marvell loss has impacted the books and how far the Lumilens order has progressed.

If management delivers credible evidence that volume production is on track, the stock could stabilize and attempt a recovery toward the 200-day average at €6.85. Further delays, escalating legal costs, or negative developments in the lawsuit would likely sustain the selling pressure. For now, POET remains a company with promising technology but a damaged narrative, racing against both its production timeline and the calendar of the court.